You are here

MediWound

US Department of Defense funds MediWound’s non-surgical burn treatment

Biopharma Reporter

Tue, 01/2/24 - 10:09 pm

Department of Defense

Upcoming events – Phase III readouts loom for Urogen and Mediwound

EP Vantage

Fri, 12/21/18 - 12:04 pm

clinical trials

urothelial cancer

Akebia, MediWound Post Gains Following IPOs

Wall St 24/7

Thu, 03/20/14 - 05:32 pm

Akebia Therapeutics